相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections
Dimpy P. Shah et al.
BLOOD (2014)
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Lorry G. Rubin et al.
CLINICAL INFECTIOUS DISEASES (2014)
Parainfluenza Virus Lower Respiratory Tract Disease After Hematopoietic Cell Transplant: Viral Detection in the Lung Predicts Outcome
Sachiko Seo et al.
CLINICAL INFECTIOUS DISEASES (2014)
Safety and Pharmacokinetics of Intravenous Zanamivir Treatment in Hospitalized Adults With Influenza: An Open-label, Multicenter, Single-Arm, Phase II Study
Francisco M. Marty et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Factors Determining Progression to Lower Respiratory Tract Disease
Yae-Jean Kim et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
DAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilation
S. Chalkias et al.
TRANSPLANT INFECTIOUS DISEASE (2014)
Outcome of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Hematopoietic Cell Transplant Recipients Receiving Aerosolized Ribavirin: Significance of Stem Cell Source and Oxygen Requirement
Sachiko Seo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipients
A. Molinos-Quintana et al.
BONE MARROW TRANSPLANTATION (2013)
Respiratory Syncytial Virus Lower Respiratory Disease in Hematopoietic Cell Transplant Recipients: Viral RNA Detection in Blood, Antiviral Treatment, and Clinical Outcomes
Alpana Waghmare et al.
CLINICAL INFECTIOUS DISEASES (2013)
Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections
Dimpy P. Shah et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients
S. Gueller et al.
TRANSPLANT INFECTIOUS DISEASE (2013)
The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation
Roy F. Chemaly et al.
BLOOD (2012)
An Adaptive Randomized Trial of an Intermittent Dosing Schedule of Aerosolized Ribavirin in Patients With Cancer and Respiratory Syncytial Virus Infection
Roy F. Chemaly et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Characteristics and Outcomes of Pandemic 2009/H1N1 Versus Seasonal Influenza in Children With Cancer
Dimpy P. Shah et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients
B. B. Guzman-Suarez et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus
Martin R. Zamora et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Management of RSV infections in adult recipients of hematopoietic stem cell transplantation
Jharna N. Shah et al.
BLOOD (2011)
Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients
Su-Mi Choi et al.
BLOOD (2011)
Treatment of Parainfluenza 3 Infection With DAS181 in a Patient After Allogeneic Stem Cell Transplantation
Yi-Bin Chen et al.
CLINICAL INFECTIOUS DISEASES (2011)
Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients
Christian Renaud et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2011)
Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181
Gallen B. Triana-Baltzer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
FilmArray, an Automated Nested Multiplex PCR System for Multi-Pathogen Detection: Development and Application to Respiratory Tract Infection
Mark A. Poritz et al.
PLOS ONE (2011)
H275Y Mutant Pandemic (H1N1) 2009 Virus in Immunocompromised Patients
Christian Renaud et al.
EMERGING INFECTIOUS DISEASES (2011)
Laninamivir Prodrug CS-8958, a Long-Acting Neuraminidase Inhibitor, Shows Superior Anti-Influenza Virus Activity after a Single Administration
Shuku Kubo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
In Vitro Antiviral Activity of Favipiravir (T-705) against Drug-Resistant Influenza and 2009 A(H1N1) Viruses
Katrina Sleeman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Detection and Control of a Nosocomial Respiratory Syncytial Virus Outbreak in a Stem Cell Transplantation Unit: The Role of Palivizumab
Christelle Kassis et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Intravenous Zanamivir for Patients with Pneumonitis due to Pandemic (H1N1) 2009 Influenza Virus
Georg Haerter et al.
CLINICAL INFECTIOUS DISEASES (2010)
Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate versus Oseltamivir for Treatment of Influenza: A Double-Blind, Randomized, Noninferiority Clinical Trial
Akira Watanabe et al.
CLINICAL INFECTIOUS DISEASES (2010)
DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: an in vitro pharmacodynamic analysis
Gallen B. Triana-Baltzer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
A Recombinant Sialidase Fusion Protein Effectively Inhibits Human Parainfluenza Viral Infection In Vitro and In Vivo
Anne Moscona et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Intravenous Zanamivir for Oseltamivir-Resistant 2009 H1N1 Influenza
Aditya H. Gaur et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro
Jack T. Nguyen et al.
PLOS ONE (2010)
A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus
John DeVincenzo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Efficacy of the New Neuraminidase Inhibitor CS-8958 against H5N1 Influenza Viruses
Maki Kiso et al.
PLOS PATHOGENS (2010)
Triple Combination of Oseltamivir, Amantadine, and Ribavirin Displays Synergistic Activity against Multiple Influenza Virus Strains In Vitro
Jack T. Nguyen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
DAS181 Inhibits H5N1 Influenza Virus Infection of Human Lung Tissues
Renee W. Y. Chan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
Marcie Tomblyn et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Palivizumab: where to from here?
Georgiana Georgescu et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation
Joshua T. Schiffer et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
The Emergency Use Authorization of Peramivir for Treatment of 2009 H1N1 Influenza
Debra Birnkrant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis
Mariana Baz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Novel Pandemic Influenza A(H1N1) Viruses Are Potently Inhibited by DAS181, a Sialidase Fusion Protein
Gallen B. Triana-Baltzer et al.
PLOS ONE (2009)
Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein
Gallen B. Triana-Baltzer et al.
PLOS ONE (2009)
Influenza vaccination in hematopoietic SCT recipients
P. Ljungman et al.
BONE MARROW TRANSPLANTATION (2008)
Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection
Angela J. Peck et al.
BLOOD (2007)
Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia
Harrys A. Torres et al.
HAEMATOLOGICA (2007)
Efficacy of orally administered T-705 on lethal avian influenza a (H5N1) virus infections in mice
Robert W. Sidwell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: The role of community respiratory viruses
Veronique Erard et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection
MP Malakhov et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Brief communication: Fatal human metapneumovirus infection in stem-cell transplant recipients
JA Englund et al.
ANNALS OF INTERNAL MEDICINE (2006)
Mechanism of action of T-705 against influenza virus
Y Furuta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo
IV Alymova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Evaluation of the Binax NOW, BD Directigen, and BD Directigen EZ assays for detection of respiratory syncytial virus
MJ Ohm-Smith et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyerresponsiveness in a murine RSV model
A Mejías et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient
DM Weinstock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Immune-globulin prophylaxis of respiratory syncytial virus infection in patients undergoing stem-cell transplantation
K Cortez et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
In vitro and in vivo activities of anti-influenza virus compound T-705
Y Furuta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome
WG Nichols et al.
BLOOD (2001)
Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: The Fred Hutchinson Cancer Research Center experience
WG Nichols et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
分享论文
